2型糖尿病とその合併症におけるフェロプトーシスを標的とする天然製品

Farshad Niazpour¹, Reza Meshkani¹

¹Department of Clinical Biochemistry, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.

Phytotherapy research : PTR

|August 27, 2025

まとめ

2型糖尿病 (T2DM) とその合併症の治療にはフェロプトーシスを抑制することで有望である. これらの化合物は細胞損傷や酸化ストレスから保護し治療戦略の可能性を秘めています

科学分野:

生物医学
細胞生物学
薬理学について

背景:

2型糖尿病 (T2DM) とその合併症は,世界的な健康上の大きな課題となっています.
固有の細胞死経路であるフェロプトーシスは,特にベータ細胞機能障害とインスリン抵抗性において,T2DMの病原化にますます関与しています.

研究の目的:

フェロプトーシスを抑制し,T2DMとその合併症を緩和する天然製品に関する現在の証拠をレビューする.
T2DMにおけるフェロプトーシスに対する天然製品の保護効果のメカニズムを調査する.

主な方法:

T2DMにおける天然製品とフェロプトーシスを調査した臨床前研究の文献レビュー.
自然製品によって調節された信号経路と分子標的の分析

主要な成果:

自然な製品は,しばしばNRF2の活性化によって,HMOX1とGPX4を上昇させ,フェロプトーシスの特徴に対抗する.
化合物は,様々な糖尿病合併症 (腎不全,網膜不全,心血管疾患など) に有効性を示しています. 重要な経路を調節することで
メカニズムは,フェロプトーシスの抑制,組織損傷の軽減,鉄代謝の調節,ミトコンドリアの完全性の保存を含む.

結論:

フェロプトーシスを標的とする天然製品は,T2DMとその合併症に対する有望な治療法です.
臨床前試験の結果を検証し,メカニズムを明らかにし,ヒト試験における安全性と有効性を評価するために,さらなる臨床研究が必要である.

キーワード:

T2DM 糖尿病の合併症フェロプトーシス自然産物 2型糖尿病

さらに関連する動画

06:50

Extraction and Analysis of Taiwanese Green Propolis

Published on: January 7, 2019

8.6K

08:18

Preparation of Naringenin Solution for In Vivo Application

Published on: August 10, 2021

3.4K

関連する概念動画

01:16

Necrosis

4.8K

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...

4.8K

01:46

Electron Transport Chain: Complex I and II

15.0K

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...

15.0K

01:15

Diabetes: Management and Pharmacotherapy

354

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...

354

01:24

Parkinson's Disease: Treatment

376

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...

376

01:22

Diabetes Mellitus: Type 2 and Gestational

2.9K

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...